NASDAQ:AYTU
Aytu BioPharma, Inc.
- Stock
Last Close
3.24
13/05 20:00
Market Cap
15.87M
Beta: −0.41
Volume Today
59.95K
Avg: 68.94K
PE Ratio
−0.52
PFCF: 3.71
Jun '14 | Jun '15 | Jun '16 | Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 19.72K - | 282.07K 1,330.33% | 918.46K 225.61% | 1.33M 44.33% | 1.39M 4.82% | 5.72M 311.64% | 13.17M 130.24% | 13.59M 3.23% | 11.42M 15.98% | ||
average payables | 327.67K - | 923.16K 181.73% | 2.36M 155.46% | 2.87M 21.70% | 2.17M 24.39% | 2.21M 1.77% | 7.06M 219.72% | 15.54M 120.08% | 15.12M 2.69% | 12.23M 19.10% | |
average receivables | 78.53K - | 159.74K 103.42% | 345.23K 116.12% | 553.41K 60.30% | 1.16M 109.57% | 3.46M 198.19% | 16.68M 382.19% | 24.94M 49.58% | 25.32M 1.53% | ||
book value per share | 596.60K - | 1.12M 86.97% | 219.24K 80.34% | 19.42K 91.14% | 4.03K 79.22% | 181.87 95.49% | 420.50 131.21% | 164.29 60.93% | 31.36 80.91% | 11.79 62.39% | |
capex per share | -1.03K - | -48.98K - | -541.79 98.89% | -22.45 95.86% | -1.54 93.16% | ||||||
capex to depreciation | -0.10 - | -2.58 - | -0.03 99.01% | -0.03 12.75% | -0.02 23.88% | ||||||
capex to operating cash flow | 0.00 - | 0.21 - | 0.01 96.18% | 0.00 41.93% | 0.00 7.67% | ||||||
capex to revenue | -0.16 - | -0.88 - | -0.03 96.06% | -0.02 41.08% | -0.01 59.95% | ||||||
cash per share | 293.29K - | 525.22K 79.08% | 197.73K 62.35% | 3.89K 98.03% | 2.11K 45.90% | 283.39 86.55% | 212.79 24.91% | 59.29 72.13% | 13.17 77.79% | 6.89 47.70% | |
days of inventory on hand | 163.39 - | 200.11 22.47% | 337.93 68.87% | 238.34 29.47% | 238.70 0.15% | 483.22 102.44% | 163.69 66.12% | 89.21 45.50% | 107.40 20.38% | ||
days payables outstanding | 4.96K - | 1.34K 72.93% | 571.80 57.40% | 377.30 34.01% | 380.78 0.92% | 571.42 50.06% | 192.91 66.24% | 90.35 53.16% | 120.67 33.56% | ||
days sales outstanding | 218.98 - | 23.14 89.43% | 59.83 158.58% | 57.72 3.52% | 86.80 50.38% | 68.37 21.23% | 156.70 129.19% | 81.98 47.68% | 98.34 19.96% | ||
debt to assets | 0.01 - | 0.11 712.16% | 0.13 23.86% | 0.12 9.28% | |||||||
debt to equity | 0.02 - | 0.21 875.06% | 0.39 91.51% | 0.42 5.35% | |||||||
dividend yield | |||||||||||
earnings yield | -0.26 - | -1.51 471.25% | -1.64 8.20% | -2.31 41.48% | -2.94 27.15% | -3.15 7.07% | -0.06 98.17% | -0.69 1,105.08% | -5.43 681.80% | -3.19 41.20% | |
enterprise value | 18.43M - | -2.25M 112.18% | 9.17M 508.23% | 8.92M 2.70% | -3.55M 139.81% | 3.92M 210.41% | 18.10M 361.58% | 62.60M 245.87% | 19.11M 69.47% | -1.29M 106.72% | |
enterprise value over ebitda | -2.95 - | 0.30 110.13% | -0.69 330.12% | -0.62 10.52% | 0.40 164.30% | -0.90 326.76% | -0.74 18.04% | -4.32 487.40% | 0.46 110.72% | 0.17 63.47% | |
ev to operating cash flow | -3.35 - | 0.34 110.10% | -0.86 354.12% | -0.65 25.02% | 0.22 134.54% | -0.28 227.24% | -0.64 125.01% | -2.41 277.97% | -0.66 72.50% | 0.25 137.79% | |
ev to sales | 312.81 - | -8.58 102.74% | 3.58 141.70% | 2.77 22.61% | -0.97 135.04% | 0.54 155.20% | 0.65 22.28% | 0.95 45.62% | 0.20 79.27% | -0.01 106.05% | |
free cash flow per share | -612.36K - | -473.87K 22.62% | -280.66K 40.77% | -67.68K 75.89% | -4.81K 92.89% | -356.44 92.59% | -125.57 64.77% | -31.01 75.31% | -19.61 36.76% | -1.54 92.16% | |
free cash flow yield | -0.26 - | -1.30 396.69% | -0.75 42.29% | -1.43 91.27% | -4.63 222.71% | -0.93 79.94% | -0.44 52.37% | -0.31 30.01% | -1.42 359.17% | -0.96 32.39% | |
graham net net | -445.23K - | 348.59K 178.29% | -103.87K 129.80% | -44.39K 57.26% | 144.38 100.33% | -373.70 358.82% | -3.80 98.98% | -58.70 1,446.46% | -34.33 41.51% | -13.91 59.48% | |
graham number | 2.88M - | 3.72M 29.00% | 1.74M 53.28% | 218.48K 87.43% | 16.67K 92.37% | 2.23K 86.65% | 393.58 82.31% | 507.28 28.89% | 229.96 54.67% | 36.83 83.99% | |
income quality | 0.99 - | 0.86 12.90% | 0.38 55.97% | 0.61 62.46% | 1.56 154.65% | 0.51 67.42% | 2.08 308.63% | 0.45 78.62% | 0.26 41.27% | 0.30 14.98% | |
intangibles to total assets | 0.68 - | 0.54 21.43% | 0.57 5.53% | 0.75 33.37% | 0.54 28.49% | 0.55 1.83% | 0.50 8.40% | 0.57 13.10% | 0.51 9.86% | 0.43 15.80% | |
interest coverage | -139.33 - | -66.37 52.36% | -3.95 94.05% | -7.94 100.92% | -26.29 231.03% | 0.25 - | |||||
interest debt per share | 5.06K - | 8.21K 62.28% | 119.38K 1,353.40% | 12.30K 89.69% | 225.19 98.17% | 8.89 - | 33.85 280.97% | 112.72 232.98% | 4.90 95.65% | ||
inventory turnover | 2.23 - | 1.82 18.35% | 1.08 40.78% | 1.53 41.78% | 1.53 0.15% | 0.76 50.60% | 2.23 195.20% | 4.09 83.48% | 3.40 16.93% | ||
invested capital | 0.02 - | 0.21 875.06% | 0.39 91.51% | 0.42 5.35% | |||||||
market cap | 21.07M - | 5.11M 75.76% | 17.22M 237.22% | 9.72M 43.54% | 3.46M 64.40% | 14.97M 332.38% | 64.17M 328.81% | 83.90M 30.74% | 20.28M 75.82% | 5.34M 73.68% | |
net current asset value | -3.34M - | 5.47M 263.64% | -4.14M 175.59% | -7.97M 92.63% | 1.83M 123.02% | -12.20M 765.00% | 17.14M 240.52% | -22.87M 233.37% | -31.60M 38.21% | -24.27M 23.19% | |
net debt to ebitda | 0.42 - | 0.98 131.68% | 0.60 38.25% | 0.06 90.84% | 0.78 1,311.61% | 2.53 223.47% | 1.87 25.93% | 1.47 21.47% | -0.03 101.93% | 0.87 3,170.82% | |
net income per share | -619.85K - | -551.67K 11.00% | -612.61K 11.05% | -109.26K 82.16% | -3.06K 97.20% | -1.21K 60.46% | -16.37 98.65% | -69.61 325.17% | -74.95 7.67% | -5.11 93.18% | |
operating cash flow per share | -611.33K - | -473.87K 22.48% | -231.68K 51.11% | -67.13K 71.02% | -4.79K 92.87% | -354.91 92.59% | -125.57 64.62% | -31.01 75.31% | -19.61 36.76% | -1.54 92.16% | |
payables turnover | 0.07 - | 0.27 269.36% | 0.64 134.75% | 0.97 51.55% | 0.96 0.91% | 0.64 33.36% | 1.89 196.21% | 4.04 113.51% | 3.02 25.13% | ||
receivables turnover | 1.67 - | 15.78 846.49% | 6.10 61.33% | 6.32 3.65% | 4.21 33.50% | 5.34 26.95% | 2.33 56.37% | 4.45 91.14% | 3.71 16.64% | ||
research and ddevelopement to revenue | 68.88 - | 13.08 81.02% | 2.47 81.14% | 0.42 83.04% | 0.05 89.05% | 0.08 75.73% | 0.06 22.58% | 0.09 37.52% | 0.15 74.34% | 0.04 74.47% | |
return on tangible assets | -1.46 - | -0.91 37.50% | -2.67 191.87% | -6.12 129.46% | -1.05 82.82% | -3.02 186.98% | -0.05 98.38% | -0.51 945.18% | -1.64 222.78% | -0.22 86.62% | |
revenue per share | 6.55K - | 18.70K 185.58% | 55.71K 197.91% | 15.64K 71.93% | 1.10K 92.97% | 187.84 82.92% | 122.29 34.90% | 78.38 35.90% | 65.77 16.09% | 32.19 51.06% | |
roe | -1.04 - | -0.49 52.40% | -2.79 464.97% | -5.63 101.39% | -0.76 86.51% | -6.65 776.88% | -0.04 99.41% | -0.42 988.20% | -2.39 464.13% | -0.43 81.87% | |
roic | -1.03 - | -0.49 52.77% | -2.80 474.69% | -5.28 88.59% | -1.16 78.01% | -4.13 255.91% | -0.06 98.60% | -0.23 290.79% | 0.58 355.19% | -0.31 152.78% | |
sales general and administrative to revenue | 39.82 - | 16.74 57.96% | 3.44 79.43% | 5.47 58.70% | 4.84 11.36% | 0.39 - | 0.32 17.02% | 0.27 17.32% | |||
shareholders equity per share | 596.60K - | 1.12M 86.97% | 219.24K 80.34% | 19.42K 91.14% | 4.03K 79.22% | 181.87 95.49% | 420.50 131.21% | 164.29 60.93% | 31.36 80.91% | 11.79 62.39% | |
stock based compensation to revenue | 8.48 - | 3.89 54.14% | 0.35 90.94% | 0.78 120.41% | 0.10 87.74% | 0.14 46.64% | 0.04 72.03% | 0.05 39.41% | 0.05 0.31% | 0.06 3.70% | |
tangible asset value | -2.83M - | 5.84M 306.43% | -3.69M 163.14% | -7.32M 98.39% | 2.06M 128.12% | -11.99M 682.72% | 18.07M 250.65% | -13.70M 175.80% | -24.54M 79.15% | -19.61M 20.08% | |
tangible book value per share | -314.51K - | 417.38K 232.71% | -80.21K 119.22% | -35.53K 55.70% | 618.52 101.74% | -307.78 149.76% | 79.97 125.98% | -16.36 120.46% | -16.70 2.06% | -5.88 64.79% | |
working capital | -2.79M - | 6.60M 336.70% | 15.80K 99.76% | -581.91K 3,782.48% | 6.08M 1,144.07% | 10.06M 65.59% | 46.66M 363.80% | -4.20M 109.01% | -4.51M 7.35% | 3.82M 184.58% |
All numbers in USD (except ratios and percentages)